“Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s636. https://doi.org/10.25251/57ey8s02.